Discontinuation of Preventive Drugs in General Practice

Research output: Contribution to conferenceConference abstract for conferenceResearch

Standard

Discontinuation of Preventive Drugs in General Practice. / Andersen, John Sahl; Lindberg, Laura Maria Glahder; Nixon, Michael Simon; Stauning, Jens Aage .

2011. Abstract from Nordisk kongres i almen medicin, Tromsø, .

Research output: Contribution to conferenceConference abstract for conferenceResearch

Harvard

Andersen, JS, Lindberg, LMG, Nixon, MS & Stauning, JA 2011, 'Discontinuation of Preventive Drugs in General Practice', Nordisk kongres i almen medicin, Tromsø, 14/06/2011.

APA

Andersen, J. S., Lindberg, L. M. G., Nixon, M. S., & Stauning, J. A. (2011). Discontinuation of Preventive Drugs in General Practice. Abstract from Nordisk kongres i almen medicin, Tromsø, .

Vancouver

Andersen JS, Lindberg LMG, Nixon MS, Stauning JA. Discontinuation of Preventive Drugs in General Practice. 2011. Abstract from Nordisk kongres i almen medicin, Tromsø, .

Author

Andersen, John Sahl ; Lindberg, Laura Maria Glahder ; Nixon, Michael Simon ; Stauning, Jens Aage . / Discontinuation of Preventive Drugs in General Practice. Abstract from Nordisk kongres i almen medicin, Tromsø, .

Bibtex

@conference{42f09ad1986849ea954b9f9d7500cdfd,
title = "Discontinuation of Preventive Drugs in General Practice",
abstract = "Introduction: In Denmark about 600,000 persons are treated for hypertension and more than 300,000 people are receiving cholesterol lowering drugs. The prevalence of hypertension in people aged 80 years is 70{\%}. For antidepressants the defined daily doses/1000 aged >80 years/day exceed 200. By far the most preventive drugs are prescribed in general practice. Special considerations exist in relation to medication of elderly patients. The prevalence of polypharmacy and the subsequent increased risk of side effects and drug interactions is high. Drug-related problems represent the fifth leading cause of death in the United States. The public expenses to drug treatment are constantly increasing. The possibility to withdraw the medication must be taken into account but the decision to discontinue drugs is complex and poorly understood. Planned studies: 1. Patients’ views upon discontinuation of preventive drugs. Qualitative interviews with patients experiencing discontinuation of preventive drugs addressing: Which attitudes do the patients have towards preventive drugs? Which thoughts do the patients have in relation to discontinuation of the drugs? How do they understand their own and the GP’s role in the process of discontinuation? 2. Doctors’ views upon discontinuation of preventive drugs. Qualitative interviews with GPs and register studies addressing: How do GPs understand discontinuation of preventive medicine as a concept? What do GPs perceive to be the barriers to discontinuation? Does an increase in preventive medicine prescription reduce the usage of lifestyle recommendations? 3. Prescription of antidepressants for elderly patients. Register studies and questionnaires to patients and GPs addressing: To whom and why are antidepressive drugs prescribed? Does the prescription pattern agree with clinical guidelines? Is discontinuation of the treatment possible?",
author = "Andersen, {John Sahl} and Lindberg, {Laura Maria Glahder} and Nixon, {Michael Simon} and Stauning, {Jens Aage}",
year = "2011",
language = "English",
note = "null ; Conference date: 14-06-2011",

}

RIS

TY - ABST

T1 - Discontinuation of Preventive Drugs in General Practice

AU - Andersen, John Sahl

AU - Lindberg, Laura Maria Glahder

AU - Nixon, Michael Simon

AU - Stauning, Jens Aage

PY - 2011

Y1 - 2011

N2 - Introduction: In Denmark about 600,000 persons are treated for hypertension and more than 300,000 people are receiving cholesterol lowering drugs. The prevalence of hypertension in people aged 80 years is 70%. For antidepressants the defined daily doses/1000 aged >80 years/day exceed 200. By far the most preventive drugs are prescribed in general practice. Special considerations exist in relation to medication of elderly patients. The prevalence of polypharmacy and the subsequent increased risk of side effects and drug interactions is high. Drug-related problems represent the fifth leading cause of death in the United States. The public expenses to drug treatment are constantly increasing. The possibility to withdraw the medication must be taken into account but the decision to discontinue drugs is complex and poorly understood. Planned studies: 1. Patients’ views upon discontinuation of preventive drugs. Qualitative interviews with patients experiencing discontinuation of preventive drugs addressing: Which attitudes do the patients have towards preventive drugs? Which thoughts do the patients have in relation to discontinuation of the drugs? How do they understand their own and the GP’s role in the process of discontinuation? 2. Doctors’ views upon discontinuation of preventive drugs. Qualitative interviews with GPs and register studies addressing: How do GPs understand discontinuation of preventive medicine as a concept? What do GPs perceive to be the barriers to discontinuation? Does an increase in preventive medicine prescription reduce the usage of lifestyle recommendations? 3. Prescription of antidepressants for elderly patients. Register studies and questionnaires to patients and GPs addressing: To whom and why are antidepressive drugs prescribed? Does the prescription pattern agree with clinical guidelines? Is discontinuation of the treatment possible?

AB - Introduction: In Denmark about 600,000 persons are treated for hypertension and more than 300,000 people are receiving cholesterol lowering drugs. The prevalence of hypertension in people aged 80 years is 70%. For antidepressants the defined daily doses/1000 aged >80 years/day exceed 200. By far the most preventive drugs are prescribed in general practice. Special considerations exist in relation to medication of elderly patients. The prevalence of polypharmacy and the subsequent increased risk of side effects and drug interactions is high. Drug-related problems represent the fifth leading cause of death in the United States. The public expenses to drug treatment are constantly increasing. The possibility to withdraw the medication must be taken into account but the decision to discontinue drugs is complex and poorly understood. Planned studies: 1. Patients’ views upon discontinuation of preventive drugs. Qualitative interviews with patients experiencing discontinuation of preventive drugs addressing: Which attitudes do the patients have towards preventive drugs? Which thoughts do the patients have in relation to discontinuation of the drugs? How do they understand their own and the GP’s role in the process of discontinuation? 2. Doctors’ views upon discontinuation of preventive drugs. Qualitative interviews with GPs and register studies addressing: How do GPs understand discontinuation of preventive medicine as a concept? What do GPs perceive to be the barriers to discontinuation? Does an increase in preventive medicine prescription reduce the usage of lifestyle recommendations? 3. Prescription of antidepressants for elderly patients. Register studies and questionnaires to patients and GPs addressing: To whom and why are antidepressive drugs prescribed? Does the prescription pattern agree with clinical guidelines? Is discontinuation of the treatment possible?

M3 - Conference abstract for conference

Y2 - 14 June 2011

ER -

ID: 34215633